A novel surface-attached carvedilol solid dispersion with enhanced solubility and dissolution.

Poor water solubility remains a major obstacle in drug formulation. Traditional solid dispersion methods often alter drug crystallinity, which can affect stability and performance. Prior research has shown that amorphous forms of drugs may dissolve faster but are less stable. However, no prior work had resolved how to improve solubility without changing crystallinity. This gap motivated the search for alternative methods. The need for environmentally friendly and industrially viable approaches also remained unmet. Existing techniques often require high-energy processes or solvents that may not be ideal for large-scale production. Thus, a new method that preserves drug crystallinity while enhancing solubility could provide a valuable solution. This paper addresses that specific challenge.

The aim of this study was to develop a novel solid dispersion method for carvedilol that improves solubility and dissolution without altering drug crystallinity. The researchers focused on optimizing the composition of the dispersion using PVP K30 and Tween 80. They sought to determine the ideal weight ratios of these components to achieve maximum solubility. The study also aimed to compare this new method with conventional solid dispersion techniques. By avoiding crystallinity changes, the method could preserve drug stability and efficacy. The researchers wanted to evaluate whether surface attachment of hydrophilic carriers could enhance dissolution. They also aimed to assess the environmental and industrial benefits of the new approach. This method could potentially be applied to other poorly water-soluble drugs.

The researchers prepared a surface-attached solid dispersion using spray-drying. They used water, PVP K30, and Tween 80 as components. The weight ratios of Tween 80 to PVP K30 and carrier to drug were systematically varied. Optimization was based on aqueous solubility measurements of carvedilol. The solid dispersions were analyzed using SEM, DSC, and XRD to assess crystallinity. These techniques confirmed that the drug's crystalline form remained unchanged. The method relied on surface attachment rather than encapsulation or amorphization. The team tested the dissolution rate and solubility of the optimized dispersion.

The optimized solid dispersion had a CV/PVP K30/Tween 80 weight ratio of 12/4/2. This formulation improved carvedilol solubility by approximately 11,500-fold. Dissolution rate increased by about two times compared to the pure drug. SEM, DSC, and XRD analyses confirmed no change in drug crystallinity. The method achieved surface attachment of hydrophilic carriers to the drug particles. This surface modification transformed the drug from hydrophobic to hydrophilic. The new method outperformed conventional solid dispersion techniques in terms of environmental impact. Industrial viability was also demonstrated through the use of common excipients and a simple process.

The authors concluded that the novel solid dispersion method successfully enhanced carvedilol solubility and dissolution. The method preserved drug crystallinity, which is important for stability and performance. Surface attachment of hydrophilic carriers was identified as the key mechanism. The optimized formulation achieved significant improvements in solubility and dissolution. The researchers proposed that this method could be more environmentally and industrially favorable. The study suggests that this approach may be applicable to other poorly water-soluble drugs. No prior work had demonstrated such a combination of enhanced solubility and crystallinity preservation. The authors emphasized the potential for this method in pharmaceutical formulation development.